l-Arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications

References

• Bushimschi I, Yallampalli C, Chwalisz K, Garfield RE. Pre-eclampsia-like conditions produced by nitric oxide inhibition: effects of l-arginine, d-arginine and steroid hormones. Hum Reprod 1995;10:2723–2730.
   PubMedGoogle Scholar
• Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169: 1316–1320.
   PubMed Web of Science ®Google Scholar
• Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am J Obstet Gynecol 1994; 70:1458–1466.
   Google Scholar
• Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994;171:944–948.
   PubMed Web of Science ®Google Scholar
• Ramsay B, De Belder A, Campbell S, Moncada S, Martins JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 1994; 24:76–78.
   PubMed Web of Science ®Google Scholar
• Grunewald C, Kublickas M, Carlstrom K, Lunell N-O, Nisell H. Effects of nitroglycerine on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 1995;86: 600–604.
   PubMed Web of Science ®Google Scholar
• Thaler I, Amit A, Jakobi P, Eldor J. The effect of isosorbide dinitrate on uterine artery and umbilical artery flow velocity waveforms at mid-pregnancy. Obstet Gynecol 1996;88:838–843.
   PubMedGoogle Scholar
• Neri I, Valensise H, Facchinetti F, Menghini S, Romanini C, Volpe A. 24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine. Hypert Preg 1999;18:107–113.
   PubMed Web of Science ®Google Scholar
• Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrate formation and action. Hypertension 1996;28: 488–493.
   PubMed Web of Science ®Google Scholar
• Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999;33:83–89.
   PubMed Web of Science ®Google Scholar
• Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F. Effects of l-arginine on utero placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand 1996;75:208–212.
   PubMed Web of Science ®Google Scholar
• Cameron IT, Van Papendorf CL, Palmer RMJ, Smith SK, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypert Preg 1993;12:85–93.
   Web of Science ®Google Scholar
• Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. l-Arginine induced hypotension. Lancet 1991;337:683.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A. l-Arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Invest 1999;6:202–207.
   PubMedGoogle Scholar
• Neri I, Jasonni VM, Gori GF, Blasi I, Facchinetti F for the Arginine Study Group. Effect of l-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J Matern Fetal Neonatal Med, in press.
   Google Scholar
• Germain AM, Valdes G, Romanik MC, Reyes MS. Evidence supporting a beneficial role for long-term l-arginine supplementation in high risk pregnancies. Hypertension 2004;43:e1.
   PubMedGoogle Scholar
• Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 2005;35:32–37.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100:369–377.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Lindheimer M, Hauth J, Caritis S, Vandorsten P, Klebanoff M. Risk factors for preeclampsia, abruption placentae and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998;339:667–671.
   PubMed Web of Science ®Google Scholar
• Staff AC, Berge L, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with l-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 2004;83:103–107.
   PubMed Web of Science ®Google Scholar
• Rytlewski K, Olszanecki R, Lauterbach R, Grzyb A, Basta A. Effects of oral l-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. Basic Clin Pharmacol Toxicol 2006;99:146–152.
   PubMed Web of Science ®Google Scholar
• Rytlewski K, Olszanecki R, Lauerbach R, Grzyb A, Kiec-Wilk B, Dembinska-Kiec A, Basta A. Effects of oral l-arginine on the pulsatility indices of umbilical artery and middle cerebral artery in preterm labor. Eur J Obstet Gynecol Reprod Biol 2008;138:23–26.
   PubMed Web of Science ®Google Scholar
• Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Library 2007;4.
   Google Scholar
• Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70:323.
   PubMed Web of Science ®Google Scholar
• Von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Karen G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;87:355.
   Google Scholar